Our Approach: We are an immuno-oncology company developing a medication for more effective cancer and infectious disease treatment.
Meet the Team:
CEO & Co-Founder
Mr. Northrup brings broad experience to Stingray, having worked at Eli Lilly and Company as an executive in Finance, Marketing, Sales, Corporate Business Development and Corporate Strategy; in management consulting with Asian companies, and in founding the venturing group with Jubilant Life Sciences.
Mr. Northrup is a Certified Licensing Professional in the Licensing Executive Society, received his MBA from the Wharton School of the University of Pennsylvania in Finance, and received his BA in Economics from Northwestern University.
Chief Financial Officer
Mr. Jordan is an accomplished life sciences professional with more than 25 years of investment banking and corporate experience in negotiating strategic corporate alliances, securing international licensing agreements, building national sales teams, and contributing to successful product development, approval and launch. Prior to joining Stingray, Scott was an investment banker with Healthios Capital Markets and employed in business development and commercialization roles with NeoPharm, Akorn Ophthalmics, and Abbot Laboratories
Mr. Jordan earned a BA from Michigan State University, Masters of Business Administration from Kellstadt Graduate School of Management (DePaul).
Sunil Sharma, MD FACP
Chief Medical Officer, Co-Founder, Inventor
Dr. Sharma is the Jon and Karen Huntsman Presidential Professor for Cancer Research, Deputy Center Director, at the Huntsman Cancer Institute at the University of Utah. Dr. Sharma has conducted over 150 clinical trials over the past 15 years.
Dr. Sharma started the G/I oncology investigational program at the Nevada Cancer Institute in Las Vegas and was in charge of several new drugs and their development with Novartis. Dr. Sharma has also worked at Sloan Kettering Memorial Hospital, one of the most prestigious cancer hospitals in the world.
Uma Bhatt, CPA
Chief Accounting Officer
Ms. Bhatt is a professional CPA with extensive hands on and executive management experience as a CFO, COO, Corporate Controller, SEC Reporting with international experience of Controllership, Business Development Executive, Internal Audit, Tax, Sarbanes-Oxley, SEC Reporting, Project Manager and Risk Management.
Mohan Kaadige, PhD
Head of Biology
Dr. Kaadige is a research scientist with a deep passion for understanding the mechanisms and signaling pathways involved in the development and progression of cancer. At TGen, Dr. Kaadige works closely with Dr. Sharma and Dr. Vankayalapati to develop targeted cancer therapy programs. The team uses a combination of computational drug design, synthetic chemistry and biology to discover small molecule inhibitors for cancer therapy. Dr. Kaadige applies his skills to investigate proof of mechanism for novel inhibitors.